The US Polyhydroxyalkanoate (PHA) Market size was valued at USD 138 Million in 2025 and is expected to reach USD 825 Million by 2035, growing at a CAGR of 19.5% from 2024 to 2035.
The economic impact of tariffs on "US Polyhydroxyalkanoate (PHA) Market".
US Polyhydroxyalkanoate (PHA) Market Growth Drivers
Increasing Demand for Biodegradable Plastics: Heightened environmental awareness and stringent regulations against single-use plastics have significantly boosted demand for biodegradable alternatives like PHA. As government agencies such as the U.S. Environmental Protection Agency (EPA) implement more rigorous mandates, companies like Danimer Scientific are expanding their PHA production capacities to meet rising demand from packaging and food service sectors. The increased adoption by major brands seeking eco-friendly packaging solutions is expected to remain a primary growth driver over the coming decade.
Corporate Sustainability Commitments: Fortune 500 companies are increasingly committing to sustainability goals and demanding biodegradable solutions across their supply chains. Leading firms such as Avient Corporation have partnered with PHA manufacturers to provide sustainable bio-based polymers as part of their product portfolios. These partnerships not only foster innovation but also expand the commercial applications of PHAs in automotive parts, consumer goods, and agriculture, leveraging government incentives and green procurement policies.
US Polyhydroxyalkanoate (PHA) Market Trends
Expansion in Food Packaging Sector: The shift towards greener packaging has accelerated PHA adoption in the US food packaging industry. For instance, CJ Biomaterials recently introduced PHA-based resins for food service ware and flexible packaging, catering to consumer preference for compostable and sustainable materials. This trend is expected to intensify as more retailers and food manufacturers emphasize circular economy initiatives.
Technological Advancements in Fermentation: Companies are investing in advanced fermentation technologies to improve yields and lower costs of PHA production. Yield10 Bioscience, for example, has made significant progress in genetically engineered bacteria to increase PHA content in biomass, thus making large-scale, cost-effective production feasible and attractive for wider industry adoption.
US Polyhydroxyalkanoate (PHA) Market Opportunities
Expansion into Medical Applications: Ongoing R&D is paving the way for PHA utilization in biodegradable medical implants and controlled drug release systems. Novomer has begun collaborations with healthcare firms to prototype PHA-based medical devices, presenting a lucrative growth opportunity in the biomedical sector.
Government Funding and Subsidies: Recent federal initiatives supporting American-made bioplastics, such as USDA’s BioPreferred Program, provide financial incentives for companies to develop and scale up PHA production, thus accelerating market penetration and innovation in the sector.
US Polyhydroxyalkanoate (PHA) Market Revenue (USD Million), 2020-2035
The chart displays consistent growth in the US PHA market from 2020 to 2035. Starting at USD 25 million in 2020, the market shows gradual acceleration in annual revenues, attributed to increasing regulatory support and investment in sustainable materials. By 2025, revenues rise to USD 138 million as commercial adoption expands. After 2027, stronger compound annual growth is evident, reflecting scaling production and new applications in packaging and medical devices. By 2035, the market is projected to reach USD 825 million, demonstrating robust long-term potential driven by environmental concerns and innovation in biopolymers.
US Polyhydroxyalkanoate (PHA) Market Share by Region, 2025 (%)
The 2025 regional market share pie chart shows the dominance of the Midwest with 38%, reflecting concentration of PHA production plants and feedstock suppliers. The West follows with 27% due to active biotechnology clusters in California. The South holds a 19% share, benefitting from strong agricultural output and state R&D incentives. The Northeast represents 12%, home to several emerging biotech startups. Other regions collectively account for 4%. This geographic distribution elucidates both existing infrastructure and innovation hubs pivotal to the US PHA industry’s growth.
US Polyhydroxyalkanoate (PHA) Market Recent Developments (Past 6 Months)
In February 2024, Danimer Scientific announced the expansion of its Bainbridge, Georgia facility, increasing annual PHA production by 50%. This strategic investment aims to meet surging demand from US food and beverage packaging converters, solidifying Danimer’s position as a leading domestic supplier of biodegradable polymers.
Yield10 Bioscience secured a patent in April 2024 for novel genetically-modified bacteria strains with improved PHA yield. This breakthrough should lower production costs and spur broader adoption in consumer packaging, agricultural films, and specialty applications.
In May 2024, CJ Biomaterials partnered with a major US retailer to trial PHA-based compostable bags in stores across California and Texas. The pilot aligns with state-level plastic reduction mandates and is a significant step towards large-scale commercialization of PHA-based flexible packaging in US retail.
Press Releases